Alma Lasers, a Sisram Medical company specializing in energy-based medical and aesthetic solutions, announced the debut of the latest edition of its aesthetics platform, Alma Harmony, featuring upgrades to offer more treatment possibilities.

The new platform is powered by five technologies, integrated to provide a range of treatments for almost any indication or skin type: 

• the Q-Switch laser stimulates collagen and treats pigmentation by targeting dermal layers, 
• the fractional ablative laser creates pixel-sized perforations in the skin, inducing rejuvenation while preserving surrounding tissues for quicker recovery, 
• intense pulsed light offers a balanced approach to aesthetic improvements across a range of patient skin types and concerns, 
• non-ablative lasers rejuvenate skin by promoting collagen production from within the dermis, and 
• the green diode laser treats vascular lesions, aiming to enhance both efficacy and safety.

With up to a 45% increase in energy*, the new multiplatform offers the capabilities of standalone lasers in a single platform. This enhanced energy enables practitioners to address the diverse needs of patients—across different ages, skin types, and treatment goals—and to provide clinically proven treatments for the most in-demand categories, such as skin resurfacing, skin rejuvenation and tightening, hair removal, acne and acne scars, vascular lesions, pigmented lesions, and tattoo removal, to name a few.

Updated Platform Focuses on Workflow Efficiency and Multi-Technology Integration

Designed to enhance efficiency, simplicity, and ease of use, the new Alma Harmony includes automated features such as customizable presets, ergonomically designed applicators, and functionality that makes operation seamless.

“The majority of the skin conditions we treat need more than one light or laser at the same time in the same session, and to work with a platform where you can have very easy connection enables us to do really personalized treatments with multiple wavelengths, multiple lights, to achieve the depth and the chromophore we want to target to achieve good results in those specific diseases,” says Pablo Naranjo, MD, PhD, medical director of Elite Laser Clinic & Laser Unit at NISA Hospital, Madrid, Spain, in a release.  “The new Alma Harmony allows me to have the same power as standalone lasers in an all-in-one platform and to achieve the next level of results with my patients.” 

Lior Dayan, CEO of Alma, adds in a release, “Alma Harmony sets a new standard for functionality, versatility, and performance. The new flagship multiplatform allows professionals to combine synergetic technologies to effectively treat a wide range of aesthetic concerns, addressing the growing consumer demand for combination procedures for longer-lasting results and a shorter recovery, while enhancing both practitioner efficiency and patient experience to unprecedented levels.”

Aiming to support clinic business offerings and increase visibility, Alma is launching the new platform together with Harmony Bio-Boost, a branded treatment tackling skin rejuvenation.

Harmony Bio-Boost, currently exclusive to Alma Harmony users, harnesses the skin’s natural healing process and leverages the power of biostimulation to deliver results. This treatment is designed to improve skin tone and texture and serves as a catalyst for collagen renewal and elastin production that continues to work up to six months** post-treatment.

*Compared to Harmony XL PRO using specific parameters 

**After a non-ablative fractional laser treatment.

Photo caption: Alma Harmony

Photo credit: Alma Lasers

Related Read:

Developed in partnership with Cutera, a provider of laser and energy-based systems for dermatologists and aesthetic practitioners worldwide, AviClear is a U.S. FDA-cleared energy-based device that treats mild, moderate, and severe acne. AviClear not only reduces existing acne but also minimizes the intensity and frequency of future breakout episodes, leading to improved overall skin health.

Rohit Jaiswal, MD, a board-certified plastic surgeon and the medical director for DrSkin Med Spa, expresses his enthusiasm for AviClear, stating that previous treatments for moderate to severe acne had shown limited durability and efficacy. 

AviClear’s effectiveness has earned it the title of “Best Laser Treatment for Acne” by Cosmopolitan Magazine. It is suitable for all skin types and utilizes a 1,726 nm wavelength that selectively targets sebaceous glands, ensuring no damage to surrounding healthy tissue. Patients typically observe a reduction in acne lesions after the first treatment, with more than 50% experiencing improvement after just three treatments. Results are long-lasting, with acne clearance visible for up to two year,s according to clinical studies.

AviClear also serves as a preventive measure for younger patients entering puberty, effectively stopping acne before it starts. With no side effects, this laser technology is suitable for those seeking a more natural approach to acne treatment or for individuals who wish to avoid the use of drugs or oral/topical medications that may cause unwanted side effects or skin irritations, enthusiasts say.

A new study published in Lasers in Surgery and Medicine (LSM), the official journal of the American Society of Laser Medicine and Surgery Inc (ASLMS), looked at changes in scar melanin index after CO2 FLSR via noninvasive probe measurement in patients of various Fitzpatrick skin types. The study, led by Sanjana Kurup and titled, “Treatment of burn hypertrophic scar with fractional ablative laser-assisted drug delivery can decrease levels of hyperpigmentation,” was selected as the May 2023 Editor’s Choice.

“This work is important because it is the first extensive study of fractional ablative laser treatment for patients with skin of color,” said Kurup. “Unlike what has been commonly reported, patients with baseline dark skin pigmentation can be treated with these types of lasers to treat burn scars.”

Sixty-three patients began a course of FLSR between October 2019 and December 2022 and underwent at least two procedures with corresponding pre- and postoperative evaluations. 

The study found that the majority of patients showed an improvement in hyperpigmentation after FLSR. According to the authors, the data from this study leads us one step closer to being able to develop interventions for hyperpigmentation that are even more effective.

Sanjana Kurup is a 4th-year medical student at Howard University College of Medicine. She will be pursuing her dermatology residency next academic year at Howard University. She conducted research in the burn research lab at MedStar Health Research Institute under the guidance of Dr Bonnie Carney and Dr Taryn Travis. 

Advalight President Travis Mahan spoke about the partnership, commenting: “We are excited to partner with Dr. Barrett to offer the ADVATx to address patients’ skin concerns from vascular, acne, and scarring to wrinkles; hyperpigmentation (including melasma); and sun damage with one of the most sophisticated lasers in the market. Dr. Barrett’s passion for results with minimal downtime perfectly aligns with ADVATx’s technology and the incredible results we continue to see.”

ADVATx combines the standard wavelength for eliminating vascular abnormalities with the new standard for non-ablative resurfacing. This allows physicians and healthcare providers to treat 25 U.S.FDA-/CE-cleared indications ranging from vascular abnormalities to rosacea, acne, wrinkle reduction, melasma, and hyperpigmentation on virtually all skin types, according to Advalight officials.

Two of the treatment options with the ADVATx include:

• ADVA Bright: This treatment combines yellow and infrared laser energy that targets vascular components of melasma, dyschromia, sun damage, and unwanted pigment while reducing wrinkles, limiting oil production, and shrinking pore size. 
  
• ADVA Clear: Combining yellow and high-powered infrared laser energy, this treatment eliminates rosacea, acne, acne scars, and vascular abnormalities like telangiectasia, hemangiomas, and venous lakes.

Treatments will be available at Barrett Plastic Surgery this month. To Barrett, it will be a big boon to operations. 

“My practice is touted for providing natural looking results using the most cutting edge technologies and staying on the front line of emerging trends and techniques,” he says. “ADVATx fits perfectly into my current practice offerings. I am also really looking forward to incorporating the laser into my scar management protocol following surgery.”

Helios IV-785’s combination of 785nm picosecond photoacoustic effect and 1064 & 532nm nanosecond thermal effect enables clinicians to nonablatively treat a broad range of medical aesthetic indications across a wide range of Fitzpatrick Skin Types. Skin toning and brightening; benign pigmented and vascular lesion removal; and multi-color tattoo eradication, including blue and green inks, are all addressed by the combination of wavelengths and pulse durations provided by Helios OS IV-785. 

Moreover, from the laser cavity to the power supply and delivery optics, Laseroptek lasers are developed in-house and from the ground up, facilitating high performance over the lifetime of the laser. 

“Helios IV-785 represents Laseroptek’s dedication to continually develop, manufacture, and deliver technologically advanced lasers for medical and aesthetic dermatology,” says the CJ Lee, the company’s president and CEO.

“We are experiencing strong demand growth for this novel laser since its initial launch earlier this year in Korea,” he adds. “The U.S. 510(k) clearance paves the way for further expansion into more global markets, providing our distribution partners and their clinical customers a new, innovative laser system with a strong value proposition.”

EON is a non-invasive, no-skin-damage laser fat reduction procedure which uses touchless technology and robotic precision to reduce isolated pockets of fat. The U.S. FDA-cleared procedure delivers laser energy and cooling simultaneously for a comfortable experience, which is a big priority in patient care and expectations.

Johnny Franco, MD, owner of Austin Plastic Surgeon in Austin and San Antonio, Texas, uses this technology and recommends it. “EON is one of the newest devices in fat reduction,” says Franco. “It is unique in that it is a contactless laser that causes fat cell destruction without hurting or affecting the skin. After the cells are destroyed, they’re absorbed into the body over a six to eight weeks period.”

EON technology is suitable for patients that are in good physical health and already in shape with stubborn residual fat in concentrated places on the body. Patients can usually expect to see a 20% reduction over the next 6 to 8 weeks after the initial treatment.

“This procedure is fantastic for those with small, discrete areas they want to target that is still hanging around even though they maintain a good diet and exercise,” said Franco. “What’s important to understand is that this isn’t a weight-loss procedure in the traditional sense, it’s body contouring.”

Patients may opt to receive more than one treatment to see more results over time in the cumbersome spots that they want to shrink or eliminate.

There is little that patients need to do to prepare for their EON treatment. People can come in after a single consultation, either in person or via virtual consultation, and get the treatment in a short amount of time, depending on the surface size, and resume their day-to-day activities right away, according to Franco. in rare instances, some patients can experience a very mild degree of soreness in the treated area for about a day.

The lack of discomfort is another key feature of EON technology. It uses cooling jets to blow cold air onto the treated area to neutralize any feeling of heat from the laser, so most people don’t experience any pain or warm sensations during the procedure, according to Franco.

“The fact that this treatment is so effective and not invasive is a huge advantage,” said Franco. “I love it for a couple of areas that are actually difficult to treat with liposuction, like the banana rolls underneath the buttocks. It’s really a cool niche treatment for that area when traditional liposuction isn’t a good option.”

Photo courtesy of Austin Plastic Surgeon

BlissMAX is a medical aesthetic platform that offers a comprehensive solution for fat reduction, cellulite reduction, and muscle conditioning with three technologies in one platform. Like the Company’s Venus Bliss system, BlissMAX employs advanced diode laser applicators for non-invasive lipolysis of the abdomen and flanks in individuals with a BMI of 30 or less, resulting in reduction of unwanted focal fat, as well as an (MP) applicator that combines Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields with advanced VariPulse technology to reduce the appearance of cellulite.

In addition to these technologies, BlissMAX also features the Company’s FlexMAX EMS applicators, designed for muscle conditioning to stimulate healthy muscles.

“We are very pleased to receive FDA 510(k) clearance for BlissMAX, the next generation of our Venus Bliss system, earlier than anticipated. BlissMAX is an important addition to our body treatment franchise, as we believe the integration of three body treatment technologies in a single, cost-effective platform will resonate with physician customers.

“The BlissMAX provides excellent results, has little-to-no downtime and offers compelling profitability per procedure for our customers. We look forward to initiating a limited commercial launch in the US by the end of the first quarter of 2022 and believe BlissMAX will be the only device on the market to offer laser fat reduction, cellulite reduction and muscle conditioning in a single body contouring workstation.”

— Domenic Serafino, Chief Executive Officer of Venus Concept

[Source(s): Venus Concept Inc, Globe Newswire]

“This agreement substantially increases doctors’ and patients’ access to our FDA cleared technology to accelerate healing, improve blood supply, activate connective tissue and to reduce pain and inflammation by leveraging Cynosure’s impeccable reputation and extensive sales force and marketing team. This agreement should quadruple our installed base over the next three years and provide extraordinary outcomes and benefits. This partnership will also allow Softwave TRT to focus our efforts on other fields of use, including Alzheimer’s, reduced opioid consumption, and cardiology and wound care,” he says.

— John Warlick, CEO of SoftWave Tissue Regeneration Technologies

SoftWave’s patented, unique technology triggers the body’s own biological healing response. SoftWave TRT devices offer a non-invasive procedure and require no anesthesia or numbing agents.

The patented SoftWave TRT technology deploys an unfocused extracorporeal shockwave (uESWT) that promotes both a physical and biological response to accelerate healing and tissue regeneration. The patented parabolic reflector produces a wider and deeper therapeutic energy zone resulting in reduced pain and superior patient outcomes by increasing blood supply, modulating inflammation, and stimulating, activating and recruiting resident and mesenchymal cells as described in published peer-reviewed research.

[Source(s): Softwave TRT, GlobeNewswire]

The clinical report, led by Fares Salameh, MD, is titled, “Treatment of periorbital wrinkles using thermo-mechanical fractional injury therapy versus fractional non-ablative 1565 nm laser: A comparative prospective, randomized, double-arm, controlled study.” 

This study, published in Lasers in Surgery and Medicine, the official journal of the American Society for Laser Medicine and Surgery Inc, was selected as the December 2021 Editor’s Choice.

Thermo‐mechanical fractional injury therapy (Tixel, Novoxel, Israel) is a new technology that is now being used for facial skin rejuvenation. The Tixel is a non-laser, non-radiofrequency, thermomechanical fractional skin treatment device intended for cutaneous procedures requiring coagulation of soft tissue; it transfers heat to the skin directly without emitting radiation. Such technology offers a user-friendly method for performing fractional skin treatment.

The Tixel device treatment was found to be an effective and safe modality for the treatment of periorbital wrinkling, with comparable results to the 1565 nm laser but less painful.

“Periorbital wrinkles are an early manifestation of photoaging, starting as early as the third decade of life and often distressing to patients, causing them to seek rejuvenation procedures,” Salameh says. “Our study introduces a new effective and safe alternative treatment for this challenging indication.”

[Source: American Society for Laser Medicine and Surgery Inc]